FDA reviews new interpretation of study on Avandia risks
The FDA is set to weigh in on lifting safety restrictions on the diabetes drug Avandia.
News Distribution for Justice
The FDA is set to weigh in on lifting safety restrictions on the diabetes drug Avandia.